Meihua International Medical Technologies Co., Ltd. (MHUA)
NASDAQ: MHUA · Real-Time Price · USD
0.517
-0.004 (-0.76%)
Dec 3, 2024, 1:29 PM EST - Market open

Company Description

Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People’s Republic of China.

The company offers class I, II, and III disposable medical devices. Its products include disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; and disposable full anesthesia kits, medical brushes, woman’s examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation kits, medical masks, anal bags, and suction connecting tubes.

It also provides disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies.

It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People’s Republic of China.

Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies logo
Country China
Founded 1990
IPO Date Feb 16, 2022
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 617
CEO Wang Xin

Contact Details

Address:
88 Tongda Road, Touqiao Town
Yangzhou, 225000
China
Phone 86 051 4898 00199
Website meihuamed.com

Stock Details

Ticker Symbol MHUA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $10.00
CIK Code 0001835615
CUSIP Number G5966G108
ISIN Number KYG5966G1082
SIC Code 3841

Key Executives

Name Position
Wang Xin Chief Executive Officer and Director
Lianzhang Zhao Chief Financial Officer and Director

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 6, 2024 6-K Report of foreign issuer
Oct 7, 2024 6-K Report of foreign issuer
Sep 20, 2024 6-K Report of foreign issuer
Jul 1, 2024 6-K Report of foreign issuer
Jun 11, 2024 6-K Report of foreign issuer
Apr 30, 2024 424B3 Prospectus
Apr 24, 2024 20-F Annual and transition report of foreign private issuers
Apr 24, 2024 6-K Report of foreign issuer
Apr 3, 2024 6-K Report of foreign issuer